Antilipemic Agents Combination & HMG-CoA Reductase Inhibitors (Statins)

💊 Antilipemic Agents Combination & HMG-CoA Reductase Inhibitors (Statins)

S.No.	Dosage Form	Composition	Domestic Market	Export Market
309	Tablets	Fenofibrate 145/160/200 mg	Yes	Yes
310	Tablets	Pitavastatin 1/2/4 mg	Yes	Yes
311	Tablets	Pitavastatin 2mg + Fenofibrate 67.5mg	Yes	Yes
312	Tablets	Pitavastatin 2/4mg + Ezetimibe 10mg	Yes	Yes
313	Tablets	Simvastatin 10/20/40mg	Yes	Yes

Disclaimer: This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence-based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Any liability for patent infringement is at the buyer's risk. The website does not sell/purchase any medicine.